Wednesday, December 31, 2025 | 05:25 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Data story: India logs 14,830 new Covid cases, active tally at 147,512

India has so far administered 2,025,057,717 vaccine doses

Covid vaccine
premium

Business Standard New Delhi
India reported a decrease of 3,365 in active coronavirus cases to take its count to 147,512. The country is twenty-ninth among the most affected countries globally by active cases. On July 26, it added 14,830 cases to take its total caseload to 43,920,451. And, with 36 new fatalities, its Covid-19 death toll reached 526,110 , or 1.20 per cent of total confirmed infections.
 
With 3,042,476 more Covid-19 vaccine doses being administered on July 25, India’s total count of vaccine shots so far reached 2,025,057,717. The count of recovered coronavirus cases across India, meanwhile, reached 43,246,829 — or 98.47 per cent of the total caseload — with 18,159 new cured cases being reported on July 26.
  • India has added 137,389 cases in the past 7 days.
  • India has so far administered 2,025,057,717 vaccine doses.
  • The count of active cases across India on July 26 saw a decrease of 3,365, compared with 1,323 on July 25.
  • With 18,159 new daily recoveries, India’s recovery rate stands at 98.47%, while the fatality rate remained unchanged at 1.21%.
  • India’s new daily closed cases stand at 18,195 — 36 deaths and 18,159 recoveries.
  • India on July 25 conducted 426,102 coronavirus tests to take the total count of tests conducted so far in the country to 873,185,917.
  • The five most affected states by total cases are Maharashtra (8035046), Kerala (6710792), Karnataka (3996717), Tamil Nadu (3534246), and Andhra Pradesh (2330067).
  • The five states with the most active cases are West Bengal (22657), Kerala (18869), Tamil Nadu (15093), Maharashtra (14534), and Karnataka (8896).
  • The five states with the highest fatalities are Maharashtra (148068), Kerala (70393), Karnataka (40133), Tamil Nadu (38032), and Delhi (26303).